Migraines: Can New Antibody Treatment Help Stop Treatment Resistant Migraines

Approximately 12% of Americans experience migraines. For some people, the attacks are so frequent and painful that episodes can be incapacitating. Historically, doctors have tried a variety of approaches to treating the condition, including drugs that numb nerves, medications that constrict blood flow, and as well as a variety of behavioral approaches. While some patients have found relief using these methods, many are not helped … Continue reading Migraines: Can New Antibody Treatment Help Stop Treatment Resistant Migraines

Organs-on-Chips: A promising future for therapeutic drugs

by Garrett Dunlap figures by Rebecca Clements  It’s no secret – pharmaceuticals are expensive for the patients who need them. One major reason for this is the cost and time needed to bring a drug to market. In our current medication pipeline, many drugs will ultimately fail during the process of development, which influences this cost. But could a better, less costly drug development process … Continue reading Organs-on-Chips: A promising future for therapeutic drugs

Risky Business: The far-reaching consequences of slashing the orphan drug tax credit

by Christopher Gerry The routes that lead to a career in biomedicine are as diverse as they are plentiful, but one of my colleagues has taken a particularly unorthodox path. Sonia had just graduated from law school when she learned of a “typo” in her genetic code that will almost certainly induce a fatal and untreatable brain disorder called prion disease. She and her husband, … Continue reading Risky Business: The far-reaching consequences of slashing the orphan drug tax credit

Expanding the Antibiotic Arsenal: A New Drug of Last Resort

Prior to the discovery of antibiotics, bacterial infections were the leading cause of death worldwide. Now, treating infections is often a routine procedure – simply requiring a doctor’s visit and a prescribed antibiotic. However, this simple routine has become marred by the emergence of antibiotic resistance. The misuse and overuse of antibiotics is fueling the rise of resistant bacteria. In response to antibiotic exposure, bacteria have evolved … Continue reading Expanding the Antibiotic Arsenal: A New Drug of Last Resort

Microbial Physicians: Delivering drugs with bacteria

by Benika Pinch Fancy a pill packed with bacteria? Researchers are investigating using genetically modified bacteria, taken in pill form, to treat human disease. Informally, they are called “designer probiotics”. But, unlike probiotics (microorganisms with known health benefits), they can’t be obtained via a serving of yogurt from your local supermarket. Rather, the bacteria in question are feats of genetic engineering and are specifically designed … Continue reading Microbial Physicians: Delivering drugs with bacteria